Highlights

Prednisolone or pentoxifylline is recommended for treatment of severe alcoholic hepatitis

2013

Scholarcy highlights

  • Whether combination therapy offers added benefit is not known
  • Prednisolone or pentoxifylline is recommended for treatment of severe alcoholic hepatitis
  • The authors report that treatment with pentoxifylline and prednisolone, compared with prednisolone alone, did not result in improved 6-month survival
  • The authors report that individual incentives, but not practice-level incentives or a combination of individual and practicelevel incentives, resulted in greater blood pressure control and appropriate response to uncontrolled blood pressure
  • In an Editorial, Dolor and Schulman discuss the financial incentives in primary care practice and achievement of population health goals
  • Bardach and colleagues found that compared with control practices, those randomly assigned to a P4P incentive program achieved modest improvements in cardiovascular care processes and outcomes
  • NEWS & ANALYSIS 1011 Medical News & Perspectives 2013 Lasker Awards Honor Biomedical Researchers and Champions of Public Service Mediterranean Diet May Reduce Stroke Incidence in Individuals With Genetic Predisposition to Diabetes FDA Warning and Study Highlight Fluoroquinolone Risks 1015 Capitol Health Call Hearing Raises Questions on Energy Drink Marketing FDA Remains Hampered in Inspecting Compounding Facilities Order Calls for Safer Practices at Chemical Facilities Self-referral Boosts Costly Cancer Treatment 1016 News From the Centers for Disease Control and Prevention Head to the Islands for a Longer, Healthier Life Span, Says Study Lunch Trucks Are Vehicle for Salmonella Outbreak in Canada Expanded Window for VariZIG Life Expectancy Gap Narrows

Need more features? Save interactive summary cards to your Scholarcy Library.